» Articles » PMID: 29221480

Prevalence and Etiologies of Pulmonary Hypertension in Africa: a Systematic Review and Meta-analysis

Overview
Journal BMC Pulm Med
Publisher Biomed Central
Specialty Pulmonary Medicine
Date 2017 Dec 10
PMID 29221480
Citations 19
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Despite the recent increasing worldwide attention towards pulmonary hypertension (PH), its epidemiology remains poorly described in Africa. Accordingly, we performed a systematic review and meta-analysis of PH prevalence, incidence and etiologies in Africa.

Methods: We searched PubMed, EMBASE, African Journals Online, and Africa Index Medicus. Published observational studies until September 20, 2017, including adult participants residing in Africa were considered. Two review authors independently selected studies, assessed included studies for methodological quality, and extracted data. A random-effects model was used for meta-analysis. Heterogeneity was evaluated by the χ test on Cochrane's Q statistic which is quantified by I values. Using Newcastle-Ottawa Scale, we considered a score of 0-4, 5-7, and 8-10 as indicative of high, moderate, and low risk of bias in included studies, respectively.

Results: Of 1611 entries, 25 studies were retained. Twelve (48%), seven (28%), and six (24%) papers had respectively a low, moderate and high risk of bias. The prevalence of PH widely varied across different populations: 9.8% (95% confidence interval: 3.2-19.3; I = 99.4%; 6 studies) in 11,163 people presenting with cardiac complaints; 10.6% (4.3-19.1; I = 90.3%; 4 studies) in 937 HIV-infected people; 32.9% (17.6-50.4; I = 97.2%; 3 studies) in 2077 patients with heart failure; 23.2% (15.2-32.2; I = 59.4%; 3 studies) in 248 patients on hemodialysis; 12.9% (11.8-14.0; I = 79.7%; 2 studies) in 3750 patients with rheumatic heart disease; 36.9% (29.7-44.3; I = 79.7; 2 studies) in 79 patients with sickle cell disease; 62.7% (49.0-74.7; 1 study) in 51 patients with chronic obstructive pulmonary disease; 25.4% (16.3-37.3; 1 study) in 63 patients with systemic lupus erythematous; 68.7% (62.8-74.1; 1 study) in 259 patients with cardiac surgery; and 7.4% (4.6-11.9; 1 study) in 202 patients with systemic sclerosis. No study reported PH incidence. From one international study (n = 209), PH etiologies were: left heart disease (68.9%), pulmonary arterial hypertension (15.8%), lung disease and/or hypoxia (12.0%), chronic thromboembolic PH (1.9%) and unclear/multifactorial PH (15.8%).

Conclusion: The prevalence of PH is relatively high in some populations in Africa, perhaps mainly driven by left heart diseases, highlighting the need for context-specific interventions.

Citing Articles

Prevalence of pulmonary hypertension and its associated factors among chronic obstructive pulmonary diseases patients at public hospitals of Addis Ababa, Ethiopia, 2024: a facility-based cross-sectional study.

Kasse T, Elias A, Lonsako A, Agegnehu Y Front Public Health. 2024; 12:1456235.

PMID: 39659724 PMC: 11628547. DOI: 10.3389/fpubh.2024.1456235.


Pulmonary hypertension associated with left heart disease.

Maron B, Bortman G, De Marco T, Huston J, Lang I, Rosenkranz S Eur Respir J. 2024; 64(4).

PMID: 39209478 PMC: 11525340. DOI: 10.1183/13993003.01344-2024.


The prevalence of pulmonary hypertension in post-tuberculosis and active tuberculosis populations: a systematic review and meta-analysis.

van Heerden J, Louw E, Thienemann F, Engel M, Allwood B Eur Respir Rev. 2024; 33(171).

PMID: 38232991 PMC: 10792440. DOI: 10.1183/16000617.0154-2023.


Retrospective on global pulmonary hypertension clinical trials: 1999-2021.

Zheng L, Tan J, Yan Y, Wang S, Yuan P, Wu C J Thorac Dis. 2023; 15(6):3372-3385.

PMID: 37426151 PMC: 10323586. DOI: 10.21037/jtd-23-701.


Pulmonary hypertension among patients hospitalized with acute heart failure in Buea, South West Region of Cameroon.

Nkoke C, Jingi A, Noubiap J, Dzudie A Pan Afr Med J. 2023; 42:216.

PMID: 36845244 PMC: 9949280. DOI: 10.11604/pamj.2022.42.216.33076.


References
1.
Schweitzer A, Horn J, Mikolajczyk R, Krause G, Ott J . Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013. Lancet. 2015; 386(10003):1546-55. DOI: 10.1016/S0140-6736(15)61412-X. View

2.
Sliwa K, Wilkinson D, Hansen C, Ntyintyane L, Tibazarwa K, Becker A . Spectrum of heart disease and risk factors in a black urban population in South Africa (the Heart of Soweto Study): a cohort study. Lancet. 2008; 371(9616):915-22. DOI: 10.1016/S0140-6736(08)60417-1. View

3.
Legendre P, Mouthon L . [Pulmonary arterial hypertension associated with connective tissue diseases]. Presse Med. 2014; 43(9):957-69. DOI: 10.1016/j.lpm.2014.07.009. View

4.
Tueller C, Stricker H, Soccal P, Tamm M, Aubert J, Maggiorini M . Epidemiology of pulmonary hypertension: new data from the Swiss registry. Swiss Med Wkly. 2008; 138(25-26):379-84. DOI: 10.4414/smw.2008.11915. View

5.
Bigna J, Sime P, Koulla-Shiro S . HIV related pulmonary arterial hypertension: epidemiology in Africa, physiopathology, and role of antiretroviral treatment. AIDS Res Ther. 2015; 12:36. PMC: 4642627. DOI: 10.1186/s12981-015-0078-3. View